🇺🇸 FDA

Company profile · Sponsor

Chiesi

Chiesi Australia Pty Ltd

E2297BD · TGA pharma AU
Pipeline
0
Drugs
5
Patents
0

Quick answer

Chiesi (E2297BD) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 0 pipeline programs, 5 drugs, and 0 patents to this profile..

Company facts

Ticker E2297BD
Exchange TGA
Company type pharma
Headquarters AU

Pipeline (0)

No pipeline programs linked yet.

Drugs (5)

Search drugs →

  1. beclometasone + formoterol + glycopyrronium

    TRIMBOW

  2. calcitonin salmon

    MIACALCIC 100

    INJECTION approved

  3. ciclesonide

    ALVESCO 160

    NASAL approved

  4. deferiprone

    FERRIPROX

    ORAL approved

    V03AC02

  5. stiripentol

    DIACOMIT

    ORAL approved

    N03AX17

Frequently asked questions

What is Chiesi?

Chiesi (E2297BD) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 0 pipeline programs, 5 drugs, and 0 patents to this profile..

Does Chiesi have pipeline programs in our database?

No pipeline programs are currently linked to Chiesi. Programs may be added as ClinicalTrials.gov sponsor matching improves — check back or search the global pipeline directory.

Where does Chiesi company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.